Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2003 3
2004 1
2005 4
2006 6
2007 3
2008 1
2009 7
2010 3
2011 5
2012 4
2013 1
2014 4
2015 2
2016 2
2017 4
2018 2
2019 2
2020 2
2021 5
2022 4
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study.
van de Donk NWCJ, Minnema MC, van der Holt B, Schjesvold F, Wu KL, Broijl A, Roeloffzen WWH, Gadisseur A, Pietrantuono G, Pour L, van der Velden VHJ, Lund T, Offidani M, Grasso M, Giaccone L, Razawy W, Tacchetti P, Mancuso K, Silkjaer T, Caers J, Zweegman S, Hájek R, Benjamin R, Vangsted AJ, Boccadoro M, Gay F, Sonneveld P, Musto P. van de Donk NWCJ, et al. Among authors: gadisseur a. Lancet Oncol. 2023 Oct;24(10):1119-1133. doi: 10.1016/S1470-2045(23)00405-9. Epub 2023 Sep 14. Lancet Oncol. 2023. PMID: 37717583
A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need?
Michiels JJ, Gadisseur A, Van Der Planken M, Schroyens W, De Maeseneer M, Hermsen JT, Trienekens PH, Hoogsteden H, Pattynama PM. Michiels JJ, et al. Among authors: gadisseur a. Int Angiol. 2005 Mar;24(1):27-39. Int Angiol. 2005. PMID: 15876996 Review.
The 2023 Belgian clinical guidance on anticoagulation management in hospitalized and ambulatory COVID-19 patients.
Vanassche T, Engelen MM, Orlando C, Vandenbosch K, Gadisseur A, Hermans C, Jochmans K, Minon JM, Motte S, Peperstraete H, Péters P, Sprynger M, Lancellotti P, Dehaene I, Emonts P, Vandenbriele C, Verhamme P, Oury C. Vanassche T, et al. Among authors: gadisseur a. Acta Clin Belg. 2023 Dec;78(6):497-508. doi: 10.1080/17843286.2023.2241692. Epub 2023 Aug 7. Acta Clin Belg. 2023. PMID: 37548503 Review.
Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data.
Heneghan C, Ward A, Perera R; Self-Monitoring Trialist Collaboration; Bankhead C, Fuller A, Stevens R, Bradford K, Tyndel S, Alonso-Coello P, Ansell J, Beyth R, Bernardo A, Christensen TD, Cromheecke ME, Edson RG, Fitzmaurice D, Gadisseur AP, Garcia-Alamino JM, Gardiner C, Hasenkam JM, Jacobson A, Kaatz S, Kamali F, Khan TI, Knight E, Körtke H, Levi M, Matchar D, Menéndez-Jándula B, Rakovac I, Schaefer C, Siebenhofer A, Souto JC, Sunderji R, Gin K, Shalansky K, Völler H, Wagner O, Zittermann A. Heneghan C, et al. Among authors: gadisseur ap. Lancet. 2012 Jan 28;379(9813):322-34. doi: 10.1016/S0140-6736(11)61294-4. Epub 2011 Nov 30. Lancet. 2012. PMID: 22137798 Free article. Review.
Analysis of von Willebrand Disease in the "Heart of Europe".
Vangenechten I, Smejkal P, Zavrelova J, Zapletal O, Wild A, Michiels JJ, Berneman Z, Blatny J, Batorova A, Prigancova T, Penka M, Gadisseur A. Vangenechten I, et al. Among authors: gadisseur a. TH Open. 2022 Oct 19;6(4):e335-e346. doi: 10.1055/s-0042-1757635. eCollection 2022 Oct. TH Open. 2022. PMID: 36299619 Free PMC article.
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial.
Rijneveld AW, van der Holt B, de Weerdt O, Biemond BJ, van de Loosdrecht AA, van der Wagen LE, Bellido M, van Gelder M, van der Velden WJFM, Selleslag D, van Lammeren-Venema D, Halkes CJM, Fijnheer R, Havelange V, van Sluis GL, Legdeur MC, Deeren D, Gadisseur A, Sinnige HAM, Breems DA, Jaspers A, Legrand O, Terpstra WE, Boersma RS, Mazure D, Triffet A, Tick LW, Beel K, Maertens JA, Beverloo HB, Bakkus M, Homburg CHE, de Haas V, van der Velden VHJ, Cornelissen JJ; Dutch-Belgian HOVON Cooperative group. Rijneveld AW, et al. Among authors: gadisseur a. Blood Adv. 2022 Feb 22;6(4):1115-1125. doi: 10.1182/bloodadvances.2021005624. Blood Adv. 2022. PMID: 34883506 Free PMC article. Clinical Trial.
Diagnosis of deep vein thrombosis: how many tests do we need?
Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, Berneman Z, De Maeseneer M, Hermsen JT, Trienekens PH. Michiels JJ, et al. Among authors: gadisseur a. Acta Chir Belg. 2005 Feb;105(1):16-25. Acta Chir Belg. 2005. PMID: 15790198 Review.
Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools.
Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, De Maeseneer M, Hermsen JT, Trienekens PH, Hoogsteden H, Pattynama PM. Michiels JJ, et al. Among authors: gadisseur a. Semin Vasc Med. 2005 Nov;5(4):351-64. doi: 10.1055/s-2005-922480. Semin Vasc Med. 2005. PMID: 16302156 Review.
64 results